New research, led by the University of Southampton, has demonstrated that a nanoscale device, called a memristor, could be the ‘missing link’ in the development of implants that use electrical signals from the brain to help treat medical conditions.
Monitoring neuronal cell activity is fundamental to neuroscience and the development of neuroprosthetics – biomedically engineered devices that are driven by neural activity. However, a persistent problem is the device being able to process the neural data in real-time, which imposes restrictive requirements on bandwidth, energy and computation capacity.
In a new study, published in Nature Communications, the researchers showed that memristors could provide real-time processing of neuronal signals (spiking events) leading to efficient data compression and the potential to develop more precise and affordable neuroprosthetics and bioelectronic medicines.
Memristors are electrical components that limit or regulate the flow of electrical current in a circuit and can remember the amount of charge that was flowing through it and retain the data, even when the power is turned off.
Lead author Isha Gupta, Postgraduate Research Student at the University of Southampton, said: “Our work can significantly contribute towards further enhancing the understanding of neuroscience, developing neuroprosthetics and bio-electronic medicines by building tools essential for interpreting the big data in a more effective way.”
The research team developed a nanoscale Memristive Integrating Sensor (MIS) into which they fed a series of voltage-time samples, which replicated neuronal electrical activity.
Acting like synapses in the brain, the metal-oxide MIS was able to encode and compress (up to 200 times) neuronal spiking activity recorded by multi-electrode arrays. Besides addressing the bandwidth constraints, this approach was also very power efficient – the power needed per recording channel was up to 100 times less when compared to current best practice.
Co-author Dr Themis Prodromakis, Reader in Nanoelectronics and EPSRC Fellow in Electronics and Computer Science at the University of Southampton said: “We are thrilled that we succeeded in demonstrating that these emerging nanoscale devices, despite being rather simple in architecture, possess ultra-rich dynamics that can be harnessed beyond the obvious memory applications to address the fundamental constraints in bandwidth and power that currently prohibit scaling neural interfaces beyond 1,000 recording channels.”
The Latest on: Bioelectronic medicines
via Google News
The Latest on: Bioelectronic medicines
- SetPoint Medical to Present at Guggenheim 2019 MedTech Disruptors Summit on May 22, 2019 at 7:11 am
May22, 2019(GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, announced today that Murthy Simhambhatla ... […]
- Cala Health Raises $50M in Series C Funding on May 21, 2019 at 3:25 am
Cala Health, Inc., a Burlingame, Calif.-based bioelectronic medicine company developing wearable therapies for chronic disease, completed a $50m Series C financing. New investors included Novartis, ... […]
- Cala Health Raises $50 Million Series C Funding on May 21, 2019 at 3:06 am
Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announced it has completed a $50 million Series C financing. Cala Health will use the ... […]
- SetPoint Medical Reports New Data Demonstrating its Bioelectronic Medicine Effectively Reduces Crohn’s Disease Activity on May 20, 2019 at 6:51 am
VALENCIA, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced new ... […]
- electroCore Announces First Quarter 2019 Financial Results on May 14, 2019 at 2:05 am
About electroCore, Inc. electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy ... […]
- Life Sciences - IDTechEx Reports and Subscriptions on May 9, 2019 at 8:16 pm
This report covers the technological innovations in bioelectronic medicine which will drive the market to exceed $60 billion by the year 2029. The recent surge of development in medical devices for ... […]
- MedTech Market Research Report on Bioelectronic Medicine Forecasts $16.6B Market 2020-2025 on May 9, 2019 at 3:01 pm
(SAN FRANCISCO, Calif.) — NEWS: A newly published market research report from Neurotech Reports, the leading market intelligence firm in the neurotechnology industry, forecasts that the worldwide ... […]
- New Market Research Report on Bioelectronic Medicine Forecasts $16.6B Market on May 9, 2019 at 6:58 am
(MENAFN - Send2Press Newswire) SAN FRANCISCO, Calif., May 9, 2019 (SEND2PRESS NEWSWIRE) — A newly published market research report from Neurotech Reports, the leading market intelligence firm in ... […]
- New Research Report on Bioelectronic Medicine Forecasts $16.6B Market on May 9, 2019 at 4:09 am
SAN FRANCISCO, May 9, 2019 /PRNewswire/ -- A newly published market research report from Neurotech Reports, the leading market intelligence firm in the neurotechnology industry, forecasts that the ... […]
via Bing News